Busca avançada
Ano de início
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Comparative analysis of the pathological events involved in immune and non-immune TRALI models

Texto completo
Tamarozzi, M. B. [1, 2] ; Soares, S. G. [3] ; Sa-Nunes, A. [4] ; Paiva, H. H. [1, 2] ; Saggioro, F. P. [5] ; Garcia, A. B. [1, 2] ; Lucena-Araujo, A. R. [1, 2] ; Falcao, R. P. [1, 2] ; Bordin, J. O. [6] ; Rego, E. M. [1, 2]
Número total de Autores: 10
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, Div Hematol Oncol, BR-14049900 Ribeirao Preto, SP - Brazil
[2] Univ Sao Paulo, Med Sch Ribeirao Preto, Natl Inst Sci & Technol Stem Cell & Cell Therapy, BR-14049900 Ribeirao Preto, SP - Brazil
[3] Invent Biotecnol, Ribeirao Preto - Brazil
[4] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Lab Expt Immunol, Sao Paulo - Brazil
[5] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pathol, BR-14049900 Ribeirao Preto, SP - Brazil
[6] Univ Fed Sao Paulo, Hematol & Hemotherapy Div, Sao Paulo - Brazil
Número total de Afiliações: 6
Tipo de documento: Artigo Científico
Fonte: Vox Sanguinis; v. 103, n. 4, p. 309-321, NOV 2012.
Citações Web of Science: 4

Background and Objectives Transfusion-related acute lung injury (TRALI) is characterized by leukocyte transmigration and alveolar capillary leakage shortly after transfusion. TRALI pathogenesis has not been fully elucidated. In some cases, the infusion of alloantibodies (immune model), whereas in others the combination of neutrophil priming by proinflammatory molecules with the subsequent infusion of biological response modifiers (BRMs) in the hemocomponent (non-immune model) have been implicated. Our aim was to compare the pathological events involved in TRALI induced by antibodies or BRMs using murine models. Materials and Methods In the immune model, human HNA-2+ neutrophils were incubated in vitro with a monoclonal antibody (anti-CD177, clone 7D8) directed against the HNA-2 antigen and injected i.v. in NOD/SCID mice. In the non-immune model, BALB/c mice were treated with low doses of lipopolysaccharide (LPS) followed by platelet-activating factor (PAF) infusion 2 h later. Forty minutes after PAF administration, or 6 h after neutrophil injection, lungs were isolated and histological analysis, determination of a variety of cytokines and chemokines including keratinocyte-derived chemokine (KC), MIP-2, the interleukins IL-1 beta, IL-6, IL-8 as well as TNFa, cell influx and alveolar capillary leakage were performed. Results In both models, characteristic histological findings of TRALI and an increase in KC and MIP-2 levels were detected. In contrast to the immune model, in the non-immune model, there was a dramatic increase in IL-1 beta and TNFa. However, capillary leakage was only detected if PAF was administrated. Conclusions Regardless of the triggering event(s), KC, MIP-2 and integrins participate in TRALI pathogenesis, whereas PAF is essential for capillary leakage when two events are involved. (AU)

Processo FAPESP: 06/52933-7 - Analise da patogenese da injuria pulmonar aguda relacionada a transfusao (trali) em modelo in vivo.
Beneficiário:Mirela de Barros Tamarozzi
Linha de fomento: Bolsas no Brasil - Doutorado
Processo FAPESP: 07/55067-1 - Analise in vivo e in vitro da acao oncogenica da forma delta n do gene p73 na leucemia promielocitica aguda.
Beneficiário:Antonio Roberto Lucena de Araújo
Linha de fomento: Bolsas no Brasil - Doutorado
Processo FAPESP: 98/14247-6 - Center for Research on Cell-Based Therapy
Beneficiário:Marco Antonio Zago
Linha de fomento: Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs